Hjem › Crohns sygdom › New Jersey
Crohns sygdom kliniske forsøg i New Jersey
9 studier for Crohns sygdom søger deltagere på steder i New Jersey.
Byer i New Jersey
Officiel studietekst (engelsk)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- HMH Justice Marie Garibaldi Medical Plaza ( Site 5072), Hackensack
RekruttererFase 3
Alder 16 til 80 · Alle køn · Opdateret 2. okt. 2026 · NCT06430801A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Goryeb Children's Hospital, Morristown
RekruttererFase 3
Alder 2 til 17 · Alle køn · Opdateret 25. sep. 2026 · NCT05923073Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Rutgers Cancer Institute of New Jersey, New Brunswick
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Sanmora Bespoke Clinical Research Solutions LLC-Site Number: 8400123, East Orange
- Allied Health Clinical Research Organization, LLC - Freehold-Site Number: 8400014, Freehold
- Tandem-Allied Clinical Research - Somers Point-Site Number: 8400050, Somers Point
- og 1 flere
RekruttererFase 3
Alder 16 til 80 · Alle køn · Opdateret 23. sep. 2026 · NCT07184931A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Goryeb Childrens Hospital /ID# 256452, Morristown
RekruttererFase 3
Alder 2 til 17 · Alle køn · Opdateret 23. sep. 2026 · NCT05995353A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Atlantic Children's Health--Pediatric Gastroenterology, Morristown
RekruttererFase 3
Alder 2 til 17 · Alle køn · Opdateret 24. aug. 2026 · NCT05509777A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Atlantic Health - Morristown Medical Center, Morristown
RekruttererFase 3
Alder 2 til 17 · Alle køn · Opdateret 22. jun. 2026 · NCT06405087Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Goryeb Children's Hospital/Morristown Medical Center/Atlantic Children's Health, Morristown
RekruttererFase 4
Alder 6 til 17 · Alle køn · Opdateret 27. maj 2026 · NCT05781152A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Goryeb Children's Hospital, Morristown
RekruttererFase 3
Alder 2 til 17 · Alle køn · Opdateret 5. maj 2026 · NCT04779320Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.